You are here: Home » Economy & Policy » News
Business Standard

Hc Grants Stay On Orchid & #8217;S Use Of Caltrol

The Delhi High Court has issued an ex parte ad interim injunction against Orchid Chemicals & Pharmaceutical Ltd, restraining it from using the trade mark, Caltrol, or any other trade mark that is deceptively similar to Rocaltrol.

F Hoffman-La Roche AG, a Swiss company, is the registered proprietor of Rocaltrol, a medicine used to treat deficiency of Vitamin D.

Rocaltrol was introduced in India in 1997.

The product is packed and marketed in India by Nicholas Piramal on behalf of the Swiss company.

Rocaltrol is used extensively all over the world and the Swiss company has spent a huge amount of money to popularise the drug. Counsel for Hoffman Man Mohan Singh submitted that as a result of its intrinsic good quality, Rocaltrol had acquired a wide reputation and exclusive goodwill.

Singh submitted that the trade mark with the suffix, Caltrol, was exclusively associated with the Swiss company and had come to be recognised only as its product.

In July 2000, Hoffman noticed that Orchid was marketing pharmaceutical products and had adopted the trade mark, Caltrol, in respect of the same product prescribed for the treatment of vitamin D deficiency.

Singh alleged that by the adoption of a trade mark that was deceptively similar to Rocaltrol, both visually and phonetically, Orchid was infringing the Swiss company

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, June 11 2001. 00:00 IST